Psychiatry Research
Volume 136, Issue 2 , Pages 211-221 , 15 September 2005

Validation of the Investigator's Assessment Questionnaire, a new clinical tool for relative assessment of response to antipsychotics in patients with schizophrenia and schizoaffective disorder

  • Rajiv Tandon

      Affiliations

    • Department of Psychiatry (Adjunct), University of Florida, Gainesville, FL, USA
    • ,
  • Robert F. DeVellis

      Affiliations

    • Department of Health Behavior and Health Education, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
    • ,
  • Jian Han

      Affiliations

    • Biostatistics and Programming, Bristol-Myers Squibb Company, Wallingford, CT, USA
    • ,
  • Hong Li

      Affiliations

    • Global Epidemiology and Outcomes Research, Bristol-Myers Squibb Company, 5 Research Parkway, Wallingford, CT 06492-7660, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 203 677 5787; fax: +1 203 677 5797.
    • ,
  • Sophia Frangou

      Affiliations

    • Section of Neurobiology of Psychosis, Institute of Psychiatry, London, UK
    • ,
  • Serdar Dursun

      Affiliations

    • Neuroscience and Psychiatry Unit, University of Manchester, Manchester, UK
    • ,
  • IAQ Validation Study Group
    • ,
  • Jean-Noel Beuzen

      Affiliations

    • International Medical Affairs, Bristol-Myers Squibb Company, Braine-I'Alleud, Belgium
    • ,
  • William Carson

      Affiliations

    • Global Development and Commercialization, Otsuka America Pharmaceutical Inc., Princeton, NJ, USA
    • ,
  • Patricia K. Corey-Lisle

      Affiliations

    • Global Epidemiology and Outcomes Research, Bristol-Myers Squibb Company, 5 Research Parkway, Wallingford, CT 06492-7660, USA
    • ,
  • Bruno Falissard

      Affiliations

    • Department of Public Health, Hôpital Paul Brousse, Villejuif, France
    • ,
  • Darlene N. Jody

      Affiliations

    • Global Medical Marketing, Bristol-Myers Squibb Company, Princeton, NJ, USA
    • ,
  • Mary J. Kujawa

      Affiliations

    • US Medical Affairs, Bristol-Myers Squibb Company, Princeton, NJ, USA
    • ,
  • Gilbert L'Italien

      Affiliations

    • Global Epidemiology and Outcomes Research, Bristol-Myers Squibb Company, 5 Research Parkway, Wallingford, CT 06492-7660, USA
    • ,
  • Ronald N. Marcus

      Affiliations

    • Global Clinical Research, Bristol-Myers Squibb Company, Wallingford, CT, USA
    • ,
  • Robert D. McQuade

      Affiliations

    • Global Medical Marketing, Bristol-Myers Squibb Company, Princeton, NJ, USA
    • ,
  • Saurabh Ray

      Affiliations

    • Global Epidemiology and Outcomes Research, Bristol-Myers Squibb Company, 5 Research Parkway, Wallingford, CT 06492-7660, USA
    • ,
  • Pascal Van Peborgh

      Affiliations

    • Medical Affairs, Bristol-Myers Squibb Company, Lounslow, UK

Received 30 August 2004 ,Revised 17 March 2005 ,Accepted 26 May 2005.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0165-1781(05)00152-6

doi: 10.1016/j.psychres.2005.05.006

Psychiatry Research
Volume 136, Issue 2 , Pages 211-221 , 15 September 2005

Article Tools

* Image Usage & Resolution